We validated the presence of WIDs in two independent genes (HLA-B and GNAS) in patient-derived tumor samples through PCR amplification of a region spanning the deleted introns, followed by Sanger sequencing (Fig. 5d–g, Supplementary Fig. 6l–n, and Supplementary Data 1.7). This evidence concerns the gene HLA-B and neoplasm.